The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
The warmer weather is here and so are those pesky flies and insects. Learn if you should be worried about being infected with viral hepatitis from insect bites.
Continue reading »Even though you may be on a first name basis with your general practitioner, research from Germany proves that your chances for successfully eliminating the Hepatitis C virus are greater when treated by a hepatologist.
Continue reading »Of special interest for those who have relapsed after Hepatitis C pegylated interferon therapy: Medical experts are gaining insight into why some courses of treatment are unsuccessful. By aiming to eliminate the likely causes for previous failures, more non-responders may be good candidates for re-treatment.
Continue reading »Scientists have discovered a unique property of a segment of one of Hepatitis C's proteins - inhibition of HIV. Continued research on this Hepatitis C component could lead to a new therapy capable of preventing HIV from being sexually transmitted.
Continue reading »With a shocking 25 percent of Americans living with non-alcoholic fatty liver disease, California researchers claim that this condition is associated with a decline in cardiac and respiratory fitness levels.
Continue reading »Musician Gregg Allman is undergoing treatment for Hepatitis C. As one of the estimated five million Americans with this virus, Allman's fight against Hepatitis C reminds us that this disease affects people from all walks of life.
Continue reading »Presently, there are many clinical trials devoted to Hepatitis C. While participating in a study offers some people a chance at improved health, the decision to enroll must be carefully considered.
Continue reading »Scripps researchers found the protein needed to assemble Hepatitis C by using technology borrowed from molecular genetics. By altering the protein NS5A, this discovery may have significant impact on the development of new therapeutic agents.
Continue reading »When combined with pegylated interferon for Hepatitis C treatment, taribavirin may be a better option than ribavirin. Compared to ribavirin, preliminary results of a Phase IIb trial show that taribavirin is similar in viral load reduction yet superior with fewer incidences of treatment related anemia.
Continue reading »People with Hepatitis C can slow the liver's cycle of inflammation by making these three healthy lifestyle changes. By eliminating certain risk factors, one can live a long life with HCV.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
